Zosteriform cutaneous metastases of HER-2 positive breast carcinoma resolved after treatment with lapatinib

Zosteriform cutaneous metastases of HER-2 positive breast carcinoma resolved after treatment with lapatinib

Saved in:

Bibliographic Details
Main Authors:	Marcela Hernández-Coronado, Iván Alejandro Rivera-Alonso, Adrian Cuellar-Barboza, Jorge Ocampo-Candiani
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Dermatologia 2025-04-01
Series:	Anais Brasileiros de Dermatologia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962025000201003&lng=en&tlng=en
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Rare Case of Zosteriform Cutaneous Metastases from a Nasopharyngeal Carcinoma
by: Andrés González García, et al.
Published: (2015-01-01)

Targeting PGK1 as a Novel strategy to regulate the sensitivity of HER2 positive gastric cancer to lapatinib
by: Xiaochen Ni, et al.
Published: (2025-07-01)

Metastatic, Her-2 Amplified Lacrimal Gland Carcinoma with Response to Lapatinib Treatment
by: Trevor Dennie
Published: (2015-01-01)

Lapatinib plus transtuzumab for HER-2 positiva metastatic breast cancer: Experience of use
by: C. García-Muñoz, et al.
Published: (2014-03-01)

Enfermedad de Darier Zosteriforme; un patrón inusual
by: María Cristina Lotero Acevedo, et al.
Published: (1999-06-01)

Linfangioma circunscrito zosteriforme. Presentación de un caso
by: María Irene Guerrero, et al.
Published: (2013-04-01)

Idiopathic Atrophoderma of Pasini and Pierini in a Zosteriform Pattern on Face
by: Mehak Gupta, et al.
Published: (2025-01-01)

The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept study.
by: Justin Stebbing, et al.
Published: (2013-01-01)

The Prospective role of lapatinib as an adjuvant therapy in prevalent cancers: Insights from in silico analysis targeting EGFR and HER2
by: Behnaz Dolatabadi, et al.
Published: (2024-12-01)

Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study.
by: Stefania Gori, et al.
Published: (2016-01-01)

Metástasis cutánea en patrón zosteriforme de un adenocarcinoma de colon
by: Maria Alejandra Zuluaga, et al.
Published: (2019-08-01)

Development of the Rat Model of Lapatinib-Induced Diarrhoea
by: Joanne M. Bowen
Published: (2014-01-01)

Current approaches to the treatment of HER2‑positive breast cancer with brain metastases
by: T. Yu. Semiglazova, et al.
Published: (2021-06-01)

Physicochemical Characterization and Cyclodextrin Complexation of the Anticancer Drug Lapatinib
by: Gergő Tóth, et al.
Published: (2017-01-01)

Hepatocellular Carcinoma with Cutaneous Metastases
by: Suzanne Rueben, et al.
Published: (2009-01-01)

Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases
by: G. A. Dashyan, et al.
Published: (2016-06-01)

Zosteriform Dissemination of Molluscum Contagiosum Infection Diagnosed in an Immunocompetent Girl: A Rare Clinical Presentation
by: Aya Marashli, et al.
Published: (2025-03-01)

Cutaneous Metastases—Histological Particularities of Multifaceted Entities
by: Andreea Cătălina Tinca, et al.
Published: (2025-04-01)

HR+HER2− breast cancers with growth factor receptor–mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells
by: Krisha Desai, et al.
Published: (2017-03-01)

Cutaneous Metastases from Lung Adenocarcinoma
by: Yu Wang, et al.
Published: (2020-01-01)

Photodynamic therapy for cutaneous metastases of breast cancer
by: E. V. Goranskaya, et al.
Published: (2014-08-01)

Preparation and characterization of lapatinib-loaded PVP nanofiber amorphous solid dispersion by electrospinning
by: E. Bitay, et al.
Published: (2021-11-01)

Comprehensive analysis of cutaneous and uveal melanoma liver metastases
by: Annegien Broeks, et al.
Published: (2020-10-01)

Association between efficacy and skin rash following treatment with the lapatinib in metastatic breast cancer
by: Suleyman Temiz, et al.
Published: (2016-04-01)

TCHL – a phase II neo-adjuvant study assessing TCH (docetaxel, carboplatin and trastuzumab) and TCHL (docetaxel, carboplatin, rastuzumab and lapatinib) in HER-2 positive breast cancer patients: a 5-year follow-up with serum biomarker analysis
by: John Crown, et al.
Published: (2025-06-01)

The multidisciplinary management of HER2-positive breast cancer brain metastases: from new biological insights to future therapeutic options
by: Claudia von Arx, et al.
Published: (2024-12-01)

Long-term survival after multidisciplinary treatments for HER2-positive advanced gastric cancer with multiple liver and lung metastases
by: Satoshi Yoshioka, et al.
Published: (2023-08-01)

Effects of the fatty acid synthase inhibitors triclosan and lapatinib on dengue virus and Zika virus infection
by: Suthatta Sornprasert, et al.
Published: (2025-03-01)

Parotid Gland Metastases of Cutaneous Squamous Cell Carcinoma of the Head: Occult Metastases Occurrence and Their Late Manifestation
by: Zuzana Horakova, et al.
Published: (2024-01-01)

Cutaneous Basal Cell Carcinoma with Lymph Node and Pulmonary Metastases
by: Renate U. Wahl, et al.
Published: (2018-01-01)

Efficacy and safety of trastuzumab deruxtecan in HER2-positive breast cancer patients with brain metastases after failure of pyrotinib-based therapy
by: Jinmei Zhou, et al.
Published: (2025-05-01)

Lapatinib ameliorates skin fibrosis by inhibiting TGF-β1/Smad and non-Smad signaling pathway
by: Yongping Wang, et al.
Published: (2025-03-01)

Screening and identification of potential target of 1′-acetoxychavicol acetate (ACA) in acquired lapatinib-resistant breast cancer
by: Febri Wulandari, et al.
Published: (2024-12-01)

HER2+ esophageal carcinoma leptomeningeal metastases treated with intrathecal trastuzumab regimen
by: Scott A Wu, et al.
Published: (2023-09-01)

Cutaneous metastases from esophageal adenocarcinoma: Taking clues from dermoscopy
by: Bailey Patrick, BS, et al.
Published: (2025-08-01)

Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?
by: Yu Ishimine, et al.
Published: (2015-01-01)

Cellular and molecular characterization of γδ T cells in peripheral blood from patients with metastases from cutaneous and uveal melanoma
by: Tamara Alonso-Agudo, et al.
Published: (2025-07-01)

Pyrotinib-assisted whole brain radiotherapy alleviates HER2-positive advanced breast cancer and brain metastases: a prospective study in patients
by: Fulin Zhou, et al.
Published: (2025-02-01)

Radiotherapy improves survival in HER2-positive breast cancer with lung metastases: a retrospective study with artificial intelligence-based prognostic modeling
by: Tengfei Ren, et al.
Published: (2025-07-01)

Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases
by: Richa Gupta, et al.
Published: (2021-10-01)